✦ LIBER ✦

2.412 Efficacy of the NMDA antagonist (BZAD-01) in a rat model of Parkinson's disease (PD): Lesions to the thalamus

✍ Scribed by L. Truong; H. Allbutt; M. Coster; M. Kassiou; J. Henderson

Book ID: 117752972
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 55 KB
Volume: 13
Category: Article
ISSN: 1353-8020
DOI: 10.1016/s1353-8020(08)70732-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P2.005 Decreased motor coordination in t

P2.005 Decreased motor coordination in the rat model of Parkinson's disease (PD) after 20 weeks of lesion

✍ H. Gambhir; S. Vivekanandhan; S. Singh; V. Goyal; R. Mathur; M. Behari 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 61 KB

2.447 AMPA antagonists attenuate L-DOPA-

2.447 AMPA antagonists attenuate L-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned rat model of Parkinson's disease

✍ C. Kobylecki; P. Ravenscroft; A. Crossman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

NEUROPROTECTIVE EFFECTS OF A SELECTIVE N

NEUROPROTECTIVE EFFECTS OF A SELECTIVE N-METHYL-d-ASPARTATE NR2B RECEPTOR ANTAGONIST IN THE 6-HYDROXYDOPAMINE RAT MODEL OF PARKINSON'S DISEASE

✍ KR Leaver; HN Allbutt; NJ Creber; M Kassiou; JM Henderson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Fipamezole (JP-1730) is a potent α2 adre

Fipamezole (JP-1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease

✍ Juha-Matti Savola; Michael Hill; Mia Engstrom; Hannele Merivuori; Siegfried Wurs 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Previous studies in the MPTP-lesioned primate model of Parkinson's disease have demonstrated that alpha(2) adrenergic receptor antagonists such as idazoxan, rauwolscine, and yohimbine can alleviate L-dopa-induced dyskinesia and, in the case of idazoxan, enhance the duration of anti-parkinsonian acti

The NR2B-selective NMDA receptor antagon

The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease

✍ J.E. Nash; P. Ravenscroft; S. McGuire; A.R. Crossman; F.S. Menniti; J.M. Brotchi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 728 KB

On the role of P2X7receptors in dopamine

On the role of P2X7receptors in dopamine nerve cell degeneration in a rat model of Parkinson’s disease: studies with the P2X7receptor antagonist A-438079

✍ Daniel Marcellino; Diana Suárez-Boomgaard; María Dolores Sánchez-Reina; José A. 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 558 KB